Conflict of interest
AHAB, MIAA, SiH, CB, SB, PCE, AF, SuH, PK, LLF, OSP, AAT, CW, and ADK have no conflicts of interest to disclose. MG received the SysPharmPedia grant, co-financed by the Ministry of Education, Science and Sport Slovenia (MIZS) (contract number C3330-16-500106) and funded by Slovenian Research Agency (research core funding No. P3-0427). AHN has received the ERANET Systems Medicine and ZonMW grant [project number: 9003035001], which was paid to the institution. MPY received funding from ISCIII through AES and EC within the AAL framework, and the SysPharmPedia grant from the ERACoSysMed 1st Joint Transnational Call from the European Union under the Horizon 2020 (AC15/00015), and also funded by grants SAF2017-83417R and PID2020-116274RB-I00 from MICIU/AEI/10.13039/501100011033 Spanish Ministry of Science, Innovation and Universities (outside of the submitted work), by the Ramon y Cajal program (RYC-2015-17205) by MICIU/AEI/10.13039/501100011033 Spanish Ministry of Science, Innovation and Universities. She also received grant support outside of the submitted work from GlaxoSmithKline and CSL Berhing. UP received SysPharmPedia grant, co-financed by the Ministry of Higher Education, Science and Innovation Slovenia (MVZI) (contract number C3330-16-500106), Slovenian Research and Innovation Agency (research core funding No. P3-0427 and research grant No. J3-4497), and PERMEABLE grant co-financed by the Republic of Slovenia, Ministry of Higher Education, Science and Innovation (MVZI) (contract number C3330-19-252012). MK received funding from the German Ministry of Education and Research Council, the European Union, the German Ministry of Education and Research, and the Bavarian Ministry of Health. He received consulting fees from AstraZeneca, honoraria from EAACI, Novartis, Nutricia, and Pari. SJHV received support from SysPharmPediA ERANET and ZonMW, which was paid to the institution. AHM is the PI of a public-private consortium (P4O2 (Precision Medicine for More Oxygen)) sponsored by Health Holland involving many private partners that contribute in cash and/or in kind (AbbVie, Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, PeXA, Philips, Quantib-U, Smartfish, Clear, SODAQ, Thirona, Roche, TopMD, Novartis, RespiQ). She received unrestricted research grants from GSK, Boehringer Ingelheim and Vertex, and honoraria from Boehringer Ingelheim, AstraZeneca and GSK. She is the chair of a DSMB of a study on BPD in neonates.